Mereo BioPharma Group plc (MPH.L) (LON:MPH) Shares Down 1.9%

Mereo BioPharma Group plc (MPH.L) (LON:MPH) shares dropped 1.9% during mid-day trading on Tuesday . The company traded as low as GBX 26 ($0.34) and last traded at GBX 26.50 ($0.35). Approximately 49,264 shares traded hands during mid-day trading, a decline of 85% from the average daily volume of 333,975 shares. The stock had previously closed at GBX 27 ($0.35).

The stock has a market cap of £89.76 million and a price-to-earnings ratio of -0.21. The stock has a fifty day simple moving average of GBX 26.50 and a 200-day simple moving average of GBX 26.50. The company has a current ratio of 2.98, a quick ratio of 2.92 and a debt-to-equity ratio of 164.26.

About Mereo BioPharma Group plc (MPH.L) (LON:MPH)

Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.

Featured Story: Why is momentum important to successful trading?

Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.